Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone released by https://iandhci876432.blogvivi.com/39662113/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes